BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Treatment
5064 results:

  • 1. Early therapy evaluation of intra-arterial trastuzumab injection in a human breast cancer xenograft model using multiparametric MR imaging.
    Kim BK; Kim B; You SH; Jang MS; Im GH; Kim KH
    PLoS One; 2024; 19(5):e0300171. PubMed ID: 38701062
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prediction of the treatment response and local failure of patients with brain metastasis treated with stereotactic radiosurgery using machine learning: A systematic review and meta-analysis.
    Habibi MA; Rashidi F; Habibzadeh A; Mehrtabar E; Arshadi MR; Mirjani MS
    Neurosurg Rev; 2024 Apr; 47(1):199. PubMed ID: 38684566
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. D-Loop Mutations as Prognostic Markers in Glioblastoma-A Pilot Study.
    Szmyd B; Stanisławska P; Podstawka M; Zaczkowski K; Izbiński PM; Kulczycka-Wojdala D; Stawski R; Wiśniewski K; Janczar K; Braun M; Białasiewicz P; Jaskólski DJ; Bobeff EJ
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673919
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Survival Outcome Prediction in Glioblastoma: Insights from MRI Radiomics.
    Styliara EI; Astrakas LG; Alexiou G; Xydis VG; Zikou A; Kafritsas G; Voulgaris S; Argyropoulou MI
    Curr Oncol; 2024 Apr; 31(4):2233-2243. PubMed ID: 38668068
    [No Abstract]    [Full Text] [Related]  

  • 5. Radiotherapy plus temozolomide with or without anlotinib in H3K27M-mutant diffuse midline glioma: A retrospective cohort study.
    Liu C; Kuang S; Huang T; Wu J; Zhang L; Gong X
    CNS Neurosci Ther; 2024 Apr; 30(4):e14730. PubMed ID: 38644565
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Current practices of craniospinal irradiation techniques in Turkey: a comprehensive dosimetric analysis.
    Şenkesen Ö; Tezcanlı E; Alkaya F; İspir B; Çatlı S; Yeşil A; Bezirganoglu E; Turan S; Köksal C; Güray G; Hacıislamoğlu E; Durmuş İF; Çavdar Ş; Aksu T; Çolak N; Küçükmorkoç E; Doğan M; Ercan T; Karaköse F; Alpan V; Ceylan C; Poyraz G; Nalbant N; Kınay Ş; İpek S; Kayalılar N; Tatlı H; Zhu M
    Radiat Oncol; 2024 Apr; 19(1):49. PubMed ID: 38627747
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The use of a selective, nontoxic dual-acting peptide for breast cancer patients with brain metastasis.
    Cavaco M; Pérez-Peinado C; Valle J; Silva RDM; Gano L; Correia JDG; Andreu D; Castanho MARB; Neves V
    Biomed Pharmacother; 2024 May; 174():116573. PubMed ID: 38613996
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Rational and design of prophylactic cranial irradiation (PCI) and brain MRI surveillance versus brain MRI surveillance alone in patients with limited-stage small cell lung cancer achieving complete remission (CR) of tumor after chemoradiotherapy: a multicenter prospective randomized study.
    Chen M; Li R; Kong Y; Shi L; Wang J; Wang Y; Xu Y; Ji Y; Hu X
    BMC Cancer; 2024 Apr; 24(1):429. PubMed ID: 38589800
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A study on the correlations of PRL levels with anxiety, depression, sleep, and self-efficacy in patients with prolactinoma.
    Miao X; Fu Z; Luo X; Wang J; Yuan L; Zhao S; Feng Y; Huang S; Xiao S
    Front Endocrinol (Lausanne); 2024; 15():1369729. PubMed ID: 38572480
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Tucatinib Combination treatment After Trastuzumab-Deruxtecan in Patients With ERBB2-Positive Metastatic Breast cancer.
    Frenel JS; Zeghondy J; Guérin-Charbonnel C; Mailliez A; Volant E; Poumeaud F; Patsouris A; Arnedos M; Bailleux C; Cabal J; Galland L; de Nonneville A; Guiu S; Dalenc F; Pistilli B; Bachelot T; Pierga JY; Le Du F; Bocquet F; Larrouquere L; Loirat D
    JAMA Netw Open; 2024 Apr; 7(4):e244435. PubMed ID: 38568692
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Feasibility of Customized Thermoplastic Patient-Specific Helmet Bolus for Scalp Irradiation Using Volumetric-Modulated Arc Therapy Planning.
    Kim H; Lee JW; Hong S
    Technol Cancer Res Treat; 2024; 23():15330338241241898. PubMed ID: 38557213
    [No Abstract]    [Full Text] [Related]  

  • 12. Prediction of cognitive decline in older breast cancer survivors: the Thinking and Living with cancer study.
    McDeed AP; Van Dyk K; Zhou X; Zhai W; Ahles TA; Bethea TN; Carroll JE; Cohen HJ; Nakamura ZM; Rentscher KE; Saykin AJ; Small BJ; Root JC; Jim H; Patel SK; Mcdonald BC; Mandelblatt JS; Ahn J
    JNCI Cancer Spectr; 2024 Feb; 8(2):. PubMed ID: 38556480
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Intravascular large B-cell lymphoma of the eye: Literature review and new findings.
    Roditi E; Panicker S; Fung AT
    Asia Pac J Ophthalmol (Phila); 2024; 13(2):100053. PubMed ID: 38556129
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Microsurgical ventriculostomy of the third ventricle with access through a burrhole in the treatment of midly located deep-seated brain tumors].
    Pitskhelauri DI; Grachev NS; Kudieva ES; Sanikidze AZ
    Zh Vopr Neirokhir Im N N Burdenko; 2024; 88(2):5-13. PubMed ID: 38549405
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Human Epidermal Growth Factor Receptor 2-Low Breast cancer brain Metastases: An Opportunity for Targeted Systemic Therapies in a High-Need Patient Population.
    Chehade R; Nofech-Mozes S; Plotkin A; Fan KY; Das S; Sahgal A; Moravan V; Jerzak KJ
    JCO Precis Oncol; 2024 Mar; 8():e2300487. PubMed ID: 38547418
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Regulation of inflammatory response by LINC00346 via miR-25-3p-mediated modulation of the PTEN/PI3K/AKT/NF-κB pathway.
    Kim MJ; Lim SG; Cho DH; Lee JY; Suk K; Lee WH
    Biochem Biophys Res Commun; 2024 May; 709():149828. PubMed ID: 38537596
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Outcomes of Patients with Non-Small Cell Lung cancer and brain Metastases Treated with the Upfront Single Agent Pembrolizumab: A Retrospective and Multicentric Study of the ESCKEYP GFPC Cohort.
    Nannini S; Guisier F; Curcio H; Ricordel C; Demontrond P; Abdallahoui S; Baloglu S; Greillier L; Chouaid C; Schott R
    Curr Oncol; 2024 Mar; 31(3):1656-1666. PubMed ID: 38534959
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinical Management of Patients with Non-Small Cell Lung cancer, brain Metastases, and Actionable Genomic Alterations: A Systematic Literature Review.
    Khasraw M; Yalamanchili P; Santhanagopal A; Wu C; Salas M; Meng J; Karnoub M; Esker S; Felip E
    Adv Ther; 2024 May; 41(5):1815-1842. PubMed ID: 38509433
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A single bout of vigorous intensity exercise enhances the efficacy of rituximab against human chronic lymphocytic leukaemia B-cells ex vivo.
    Collier-Bain HD; Emery A; Causer AJ; Brown FF; Oliver R; Dutton D; Crowe J; Augustine D; Graby J; Leach S; Eddy R; Rothschild-Rodriguez D; Gray JC; Cragg MS; Cleary KL; Moore S; Murray J; Turner JE; Campbell JP
    Brain Behav Immun; 2024 May; 118():468-479. PubMed ID: 38503395
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Dynamic Contrast-enhanced MRI Quantification of Altered Vascular Permeability in Autoimmune Encephalitis.
    Ji SH; Yoo RE; Choi SH; Lee WJ; Lee ST; Jeon YH; Choi KS; Lee JY; Hwang I; Kang KM; Yun TJ
    Radiology; 2024 Mar; 310(3):e230701. PubMed ID: 38501951
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 254.